In our article ([1][1]), we have reported that CBX4 may serve as a tumor suppressor in colorectal carcinoma by recruiting HDAC3 to the RUNX2 promoter to impede RUNX2 expression and… Click to show full abstract
In our article ([1][1]), we have reported that CBX4 may serve as a tumor suppressor in colorectal carcinoma by recruiting HDAC3 to the RUNX2 promoter to impede RUNX2 expression and that this novel function of CBX4 depends on its interaction with HDAC3, but is independent of its SUMO E3 ligase, its
               
Click one of the above tabs to view related content.